Fmr LLC Argenx Se Transaction History

Fmr LLC

$1.81 Trillion
Q3 2025

A detailed history of Fmr LLC transactions in Argenx Se stock. As of the latest transaction made, Fmr LLC holds 5,692,346 shares of ARGX stock, worth $5.17 Billion. This represents 0.23% of its overall portfolio holdings.

Number of Shares

5,692,346

Previous 5,423,508 4.96%

Holding current value

$5.17 Billion

Previous $2.99 Billion 40.44%

% of portfolio

0.23%

Previous 0.18%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$538.64 - $768.0 $145 Million - $206 Million	268,838 Added 4.96%	5,692,346 $4.2 Billion
Q2 2025 Aug 14, 2025	SELL	$532.27 - $656.65 $128 Million - $157 Million	-239,699 Reduced 4.23%	5,423,508 $2.99 Billion
Q1 2025 May 12, 2025	BUY	$571.0 - $671.75 $25.7 Million - $30.2 Million	44,985 Added 0.8%	5,663,207 $3.35 Billion
Q4 2024 Feb 13, 2025	BUY	$520.52 - $638.33 $429 Million - $526 Million	824,750 Added 17.21%	5,618,222 $3.46 Billion
Q3 2024 Nov 13, 2024	BUY	$434.22 - $551.9 $549 Million - $698 Million	1,265,486 Added 35.87%	4,793,472 $2.6 Billion

Q2 2024 Aug 13, 2024	BUY	$356.01 - $451.55 $91.8 Million - $116 Million	257,964 Added 7.89%	3,527,986 $1.52 Billion
Q1 2024 May 13, 2024	SELL	$356.95 - $413.29 $194 Million - $224 Million	-542,350 Reduced 14.23%	3,270,022 $1.29 Billion
Q4 2023 Feb 13, 2024	SELL	$338.91 - $506.01 $391 Million - $583 Million	-1,152,601 Reduced 23.21%	3,812,372 $1.45 Billion
Q3 2023 Nov 13, 2023	SELL	$369.35 - $548.43 $33.5 Million - $49.8 Million	-90,770 Reduced 1.8%	4,964,973 $2.44 Billion
Q2 2023 Aug 11, 2023	SELL	$360.14 - $422.58 $64 Million - $75.1 Million	-177,755 Reduced 3.4%	5,055,743 $1.97 Billion
Q1 2023 May 11, 2023	BUY	$334.23 - $403.65 $8.13 Million - $9.82 Million	24,329 Added 0.47%	5,233,498 $1.95 Billion
Q4 2022 Feb 13, 2023	BUY	$342.17 - $402.31 $8.02 Million - $9.43 Million	23,437 Added 0.45%	5,209,169 $1.97 Billion
Q3 2022 Nov 10, 2022	BUY	$343.2 - $395.75 $72.5 Million - $83.7 Million	211,389 Added 4.25%	5,185,732 $1.83 Billion
Q2 2022 Aug 12, 2022	BUY	$269.58 - $378.88 $79.3 Million - $111 Million	294,228 Added 6.29%	4,974,343 $1.88 Billion
Q1 2022 May 13, 2022	BUY	$254.45 - $351.06 $23.8 Million - $32.9 Million	93,716 Added 2.04%	4,680,115 $1.48 Billion
Q4 2021 Feb 14, 2022	BUY	$272.01 - $353.03 $34.3 Million - $44.5 Million	125,986 Added 2.82%	4,586,399 $1.61 Billion
Q3 2021 Nov 15, 2021	SELL	$295.0 - $350.58 $59.2 Million - $70.4 Million	-200,749 Reduced 4.31%	4,460,413 $1.35 Billion
Q2 2021 Aug 13, 2021	BUY	$257.11 - $319.92 $1.2 Billion - $1.49 Billion	4,661,162 New	4,661,162 $1.4 Billion

Others Institutions Holding ARGX

# of Institutions

525

Shares Held

26M

Call Options Held

589K

Put Options Held

320K

View Full List

About ARGENX SE

Ticker ARGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,323,800
Market Cap $50.2B
Description
argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...

More about ARGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account